维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

1篇 您的检索式：作者名="Louis C.S.Tan"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Mild cognitive impairment in Parkinson’s disease:a distinct clinical entity?显示文摘Background:Mild cognitive impairment in Parkinson’s disease(PD-MCI)is a common clinical condition.Understanding its pathology and clinical features is important for early intervention before the onset of dementia.In the past,variable definitions and differences in neuropsychological batteries generated divergent results of the affected cognitive patterns.Main body:The introduction of PD-MCI criteria by the Movement Disorders Society(MDS)Task Force provides a more uniform system for defining and measuring PD-MCI and may improve the validity of future research.PD-MCI is likely to be heterogeneous since it can coexist with Alzheimer’s disease and/or Lewy body pathologies in PD.Pathogeneses of neuropsychiatric disturbances,such as depression,anxiety and apathy,are associated with PD with or without MCI.In addition,cognitive reserve formed by patients’unique life experiences may influence the outward cognitive performance despite the presence of the aforementioned pathogeneses and hence alter the diagnosis of MCI.Conclusion:The overlap of cognitive impairment across different neurodegenerative diseases suggests that PD-MCI is likely to result from a mixture of complex pathophysiologies,rather than being a distinct pathologic entity.Differentiating MCI from other organic symptoms in PD would facilitate novel therapeutic strategies.	Ming-Ching Wen Ling Ling Chan Louis C.S.Tan Eng King Tan	2017	Translational Neurodegeneration2017，6，1：	0

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费